<DOC>
	<DOC>NCT00841230</DOC>
	<brief_summary>The purpose of this study is to investigate whether increased tinnitus reduction can be obtained with Deanxit in patients already receiving Rivotril.</brief_summary>
	<brief_title>Deanxit and Rivotril in Tinnitus Patients</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<criteria>pure tone, narrow band noise or polyphonic tinnitus unilateral or bilateral tinnitus VAS ≥ 4 cochleair origin tinnitus tinnitus present 3 months or more age 18y or more intake Rivotril 1mg/d patient 'able to cooperate' patient able to fill in TQ en VAS No pontine angle pathology on MRI pulsatile tinnitus pregnancy or breast feeding contraindications Deanxit recovery myocard infarct conduction disorder His untreated glaucoma MAO inhibitors: 15d stop otosclerosis middle ear pathologies Ménière somatic tinnitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Tinnitus</keyword>
</DOC>